28330470|t|Involvement of apoptotic pathways in docosahexaenoic acid -induced benefit in prostate cancer: Pathway-focused gene expression analysis using RT(2) Profile PCR Array System
28330470|a|Present study aimed to better understand the potential apoptotic pathways that involved in docosahexaenoic acid (DHA)-induced apoptosis of prostate cancer cells. Human prostate cancer DU145 cells were treated with different concentrations of fish oil, omega-3 PUFA (DHA, and Eicosapentaenoic acid, EPA), or omega-6 PUFA (Arachidonic acid, AA). Cell viability and apoptosis were evaluated by MTT assay and Hoechst staining. Pathway-focused gene expression profiling of DU145 cells was analyzed with the RT(2) Profile PCR Array System. The results were verified by real time quantitative polymerase chain reaction (RT-qPCR). AA exposure showed no obvious effect on viability of DU145 cells. However, exposure with fish oil, EPA, or DHA for 24 h significantly affected cell viability. The growth inhibition of DHA was more pronounced than that of EPA and showed a time-dependent increase. DHA exposure caused typical apoptotic characteristics. Ten genes were more expressed, while 5 genes were less expressed following DHA exposure. RT-qPCR confirmed the time dependent effect of DHA on the expression of these differentially expressed genes. KEGG pathway analysis showed that DHA may induce the apoptosis of cancer cells preferentially through mediating P53, MAPK, TNF, PI3K/AKT, and NF-κB signaling pathways. Our study demonstrated the beneficial action of DHA on human prostate carcinoma cell line DU145. The pro-apoptotic effect of DHA on DU145 cells may involve mediation various pathways, especially P53, MAPK, TNF, PI3K/AKT, and NF-κB signaling pathways. Molecular mechanisms of DHA on apoptosis of cancer cells still need to be further clarified.
28330470	15	33	apoptotic pathways	T043	C3269135
28330470	37	57	docosahexaenoic acid	T109,T121	C0556150
28330470	78	93	prostate cancer	T191	C0376358
28330470	111	135	gene expression analysis	T063	C1880945
28330470	142	172	RT(2) Profile PCR Array System	T063	C3179034
28330470	228	246	apoptotic pathways	T043	C3269135
28330470	264	284	docosahexaenoic acid	T109,T121	C0556150
28330470	286	289	DHA	T109,T121	C0556150
28330470	299	308	apoptosis	T043	C0162638
28330470	312	327	prostate cancer	T191	C0376358
28330470	328	333	cells	T025	C0334227
28330470	335	340	Human	T016	C0086418
28330470	341	356	prostate cancer	T191	C0376358
28330470	357	368	DU145 cells	T025	C0334227
28330470	415	423	fish oil	T109,T121	C0016157
28330470	425	437	omega-3 PUFA	T109,T121,T123	C0015689
28330470	439	442	DHA	T109,T121	C0556150
28330470	448	469	Eicosapentaenoic acid	T109,T121,T123	C0000545
28330470	471	474	EPA	T109,T121,T123	C0000545
28330470	480	492	omega-6 PUFA	T109,T123	C0133860
28330470	494	510	Arachidonic acid	T109	C0003695
28330470	512	514	AA	T109	C0003695
28330470	517	531	Cell viability	T043	C0007620
28330470	536	545	apoptosis	T043	C0162638
28330470	564	573	MTT assay	T062	C2986858
28330470	578	594	Hoechst staining	T059	C1441607
28330470	612	637	gene expression profiling	T059,T063	C0752248
28330470	641	652	DU145 cells	T025	C0334227
28330470	736	784	real time quantitative polymerase chain reaction	T063	C3179034
28330470	786	793	RT-qPCR	T063	C3179034
28330470	796	798	AA	T109	C0003695
28330470	836	845	viability	T043	C0007620
28330470	849	860	DU145 cells	T025	C0334227
28330470	885	893	fish oil	T109,T121	C0016157
28330470	895	898	EPA	T109,T121,T123	C0000545
28330470	903	906	DHA	T109,T121	C0556150
28330470	939	953	cell viability	T043	C0007620
28330470	959	976	growth inhibition	T043	C1512773
28330470	980	983	DHA	T109,T121	C0556150
28330470	1017	1020	EPA	T109,T121,T123	C0000545
28330470	1059	1062	DHA	T109,T121	C0556150
28330470	1087	1096	apoptotic	T080	C1516044
28330470	1118	1123	genes	T028	C0017337
28330470	1153	1158	genes	T028	C0017337
28330470	1189	1192	DHA	T109,T121	C0556150
28330470	1203	1210	RT-qPCR	T063	C3179034
28330470	1250	1253	DHA	T109,T121	C0556150
28330470	1306	1311	genes	T028	C0017337
28330470	1347	1350	DHA	T109,T121	C0556150
28330470	1366	1375	apoptosis	T043	C0162638
28330470	1379	1391	cancer cells	T025	C0334227
28330470	1425	1428	P53	T044	C2984306
28330470	1430	1434	MAPK	T044	C2611831
28330470	1436	1439	TNF	T039	C1519684
28330470	1441	1449	PI3K/AKT	T169	C2984369
28330470	1455	1479	NF-κB signaling pathways	T045	C1513838
28330470	1529	1532	DHA	T109,T121	C0556150
28330470	1536	1541	human	T016	C0086418
28330470	1542	1560	prostate carcinoma	T191	C0376358
28330470	1561	1576	cell line DU145	T025	C0334227
28330470	1606	1609	DHA	T109,T121	C0556150
28330470	1613	1624	DU145 cells	T025	C0334227
28330470	1655	1663	pathways	T044	C0037080
28330470	1676	1679	P53	T044	C2984306
28330470	1681	1685	MAPK	T044	C2611831
28330470	1687	1690	TNF	T039	C1519684
28330470	1692	1700	PI3K/AKT	T169	C2984369
28330470	1706	1730	NF-κB signaling pathways	T045	C1513838
28330470	1732	1752	Molecular mechanisms	T044	C1258062
28330470	1756	1759	DHA	T109,T121	C0556150
28330470	1763	1772	apoptosis	T043	C0162638
28330470	1776	1788	cancer cells	T025	C0334227